Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value.
The aim of this study was to assess the potential clinical implications of Chlamydophila pneumoniae in patients with acute and chronic arthritic diseases and to investigate whether blood monocytes might reflect a concomitant synovial or persistent systemic infection. C. pneumoniae was investigated with advanced PCR and reverse transcriptase (RT) PCR techniques targeting different genes and combined with cell line cultures, in synovial fluid (SF) and peripheral blood mononuclear cell (PBMC) specimens collected from 28 patients with arthritis. Five out of twenty-eight patients (17.8%) were found to have C. pneumoniae DNA in either SF or PBMC specimens. Their diagnosis was reactive arthritis (ReA), S.A.P.H.O syndrome, psoriatic arthritis, undifferentiated oligoarthritis (UOA) and ankylosing spondylitis (AS). Specimens from patients with UOA and AS had also mRNA transcripts but those from AS yielded C. pneumoniae growth after co-culture. Moreover, C. pneumoniae DNA levels measured by Real-Time PCR (LightCycler) were higher in PBMC specimens compared to those found in SF at the end of antibiotic treatment. C. pneumoniae may have a role as triggering factor also in chronic arthritides including AS. The combined use of culture and molecular tools increases detection rates and improves the overall sensitivity, suggesting their potential use to detect C. pneumoniae. The different kinetics of bacterial DNA at both peripheral and synovial levels should be taken into consideration when monitoring and evaluating the effectiveness of antibiotic treatment.
Contini
Carlo
C
Department of Clinical and Experimental Medicine, Section of Infectious Diseases, University of Ferrara, via Fossato di Mortara 23, 44100, Ferrara, Italy. cnc@unife.it
Grilli
Anastasio
A
Badia
Lorenzo
L
Guardigni
Viola
V
Govoni
Marcello
M
Seraceni
Silva
S
D000208:Acute Disease; D000328:Adult; D000368:Aged; D016918:Arthritis, Reactive / Q000150:complications / Q000175:diagnosis / Q000382:microbiology*; D002478:Cells, Cultured; D023521:Chlamydophila Infections / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D016993:Chlamydophila pneumoniae / Q000235:genetics / Q000302:isolation & purification*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000091402:Prohibitins; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000175:diagnosis / Q000382:microbiology*; D055815:Young Adult
Arthritis Res. 2002;4(1):5-9
11879531
Cardiovasc Drugs Ther. 2001;15(3):259-62
11713894
Neurosci Res. 2008 Sep;62(1):58-61
18572268
Curr Opin Rheumatol. 2000 Jul;12(4):254-62
10910176
Rev Rhum Engl Ed. 1995 Mar;62(3):224
7788343
BMC Infect Dis. 2006 Nov 21;6:166
17118199
Nat Clin Pract Rheumatol. 2006 Mar;2(3):163-9
16932676
PLoS Pathog. 2009 Aug;5(8):e1000552
19714222
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S133-41
16273797
J Rheumatol. 2001 Aug;28(8):1874-80
11508594
Int J Parasitol. 2005 Mar;35(3):275-83
15722079
Br J Rheumatol. 1996 Nov;35(11):1189-90
8948316
Ann Rheum Dis. 2002 Jul;61(7):580-7
12079895
Eur J Clin Microbiol Infect Dis. 1998 Mar;17(3):211-2
9665306
Rheumatology (Oxford). 1999 Jun;38(6):504-9
10402069
Rheum Dis Clin North Am. 2003 Aug;29(3):613-29
12951871
Infection. 2009 Feb;37(1):52-5
17906838
Ann Rheum Dis. 2006 Mar;65(3):281-4
16474031
Microb Pathog. 2000 Jul;29(1):17-24
10873487
Microbiol Res. 2006;161(1):9-19
16338585
Clin Microbiol Rev. 1995 Oct;8(4):451-61
8665464
Mult Scler. 2004 Aug;10(4):360-9
15327030
Arthritis Rheum. 2005 Apr;52(4):1297-304
15818670
Arthritis Rheum. 1999 Sep;42(9):1889-93
10513803
Lancet. 1992 Jul 11;340(8811):81-2
1352016